Varano, F.; Catarzi, D.; Vigiani, E.; Vincenzi, F.; Pasquini, S.; Varani, K.; Colotta, V.
Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists. Pharmaceuticals 2020, 13, 161.
https://doi.org/10.3390/ph13080161
AMA Style
Varano F, Catarzi D, Vigiani E, Vincenzi F, Pasquini S, Varani K, Colotta V.
Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists. Pharmaceuticals. 2020; 13(8):161.
https://doi.org/10.3390/ph13080161
Chicago/Turabian Style
Varano, Flavia, Daniela Catarzi, Erica Vigiani, Fabrizio Vincenzi, Silvia Pasquini, Katia Varani, and Vittoria Colotta.
2020. "Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists" Pharmaceuticals 13, no. 8: 161.
https://doi.org/10.3390/ph13080161
APA Style
Varano, F., Catarzi, D., Vigiani, E., Vincenzi, F., Pasquini, S., Varani, K., & Colotta, V.
(2020). Piperazine- and Piperidine-Containing Thiazolo[5,4-d]pyrimidine Derivatives as New Potent and Selective Adenosine A2A Receptor Inverse Agonists. Pharmaceuticals, 13(8), 161.
https://doi.org/10.3390/ph13080161